Healthcare -
Biotechnology - NYSE - US
$ 7.61
-9.17 %
$ 806 M
Market Cap
-2.59
P/E
RCUS - REVENUE
Revenue RCUS - Arcus Biosciences, Inc.
258 M
LAST VALUE
51.78%
2 YEAR CAGR
76.65%
5 YEAR CAGR
0.00%
10 YEAR CAGR